Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NK1 Receptor Antagonist vs Placebo in the Treatment of Overactive Bladder Symptoms

NCT00321477 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00321477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00321477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NK1 Receptor Antagonist vs Placebo in the Treatment of Overactive Bladder Symptoms
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
February 28, 2007
Enrollment
160 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

incontinence, urinary and urinary bladder, overactive, overactive bladder